A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer.

ras oncogenes in human cancer: a review.

1989 • 5,116 citations

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1996 • 1,584 citations

Protein kinase Cα activates RAF-1 by direct phosphorylation

1993 • 1,282 citations

Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

1999 • 907 citations

Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria

1996 • 785 citations

Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes

1998 • 765 citations

The Function of GRB2 in Linking the Insulin Receptor to Ras Signaling Pathways

1993 • 629 citations

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1996 • 444 citations

Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1.

1996 • 364 citations

Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis

1998 • 319 citations

Interaction of the Protein Kinase Raf-1 with 14-3-3 Proteins

1994 • 285 citations

Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.

1994 • 242 citations

Characterization of a Potent and Specific Class of Antisense Oligonucleotide Inhibitor of Human Protein Kinase C-α Expression

1999 • 222 citations

Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue.

1989 • 211 citations

The potential of protein kinase C as A target for anticancer treatment

1993 • 200 citations

Phase I Evaluation of ISIS 3521, an Antisense Oligodeoxynucleotide to Protein Kinase C-Alpha, in Patients With Advanced Cancer

1999 • 174 citations

Activation of Ras by receptor tyrosine kinases.

1994 • 160 citations

Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer.

1999 • 152 citations

Protein Kinase C Isoenzyme Patterns Characteristically Modulated in Early Prostate Cancer

1999 • 144 citations

bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer

1996 • 140 citations

Quantitation of Phosphorothioate Oligonucleotides in Human Plasma

1996 • 139 citations

Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C- raf kinase supports an antisense mechanism of action in vivo

1996 • 136 citations

Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-raf-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)

1999 • 131 citations

A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer.

2000 • 128 citations

Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas.

1991 • 117 citations

12(S)-HETE Enhancement of Prostate Tumor Cell Invasion: Selective Role of PKC

1994 • 109 citations

Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences.

1987 • 95 citations

c-raf-1 depletion and tumor responses in patients treated with the c-raf-1 antisense oligodeoxynucleotide ISIS 5132 (CGP 69846A).

1999 • 77 citations

MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION

1999 • 73 citations

Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice.

1998 • 60 citations

Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.

1997 • 53 citations

Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.

2000 • 43 citations

Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents

1996 • 42 citations

The Protein Kinase C Activator, Phorbol Ester, Elicits Disparate Functional Responses in Androgen-Sensitive and Androgen-Independent Human Prostatic Cancer Cells

1998 • 40 citations

Transforming Growth Factor-β1 Inhibits Membrane Association of Protein Kinase Cα in a Human Prostate Cancer Cell Line, PC3*

1997 • 29 citations

c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells.

1994 • 18 citations